Platelet Aggregation Devices Market Size to Grow USD 613.4 million by 2029, witnessing a CAGR of 11.9%

Platelet Aggregation Devices Market

The global Platelet Aggregation Devices market was valued at US$ 270.7 million in 2022 and is anticipated to reach US$ 613.4 million by 2029, witnessing a CAGR of 11.9% during the forecast period 2023-2029.

Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-25L7374/Global_Platelet_Aggregation_Devices_Market_Insights_and_Forecast_to_2028

Blood cells called platelets are in charge of creating clots to halt internal bleeding. When a blood artery is damaged, platelets rush there to form clots that stop the flow of blood and stop the bleeding. An adequate amount of platelets are needed for precise clotting formation. The degree to which platelets adhere to one another can be assessed using platelet aggregation equipment, commonly known as an aggregometer. Such a test uses a platelet antagonist, such as ADP, thrombin, or ristocetin, to evaluate platelet aggregation.

Trends Influencing the Growth of the Global Platelet Aggregation Devices Market

Platelet Aggregation Devices Market is being driven by factors such as high output for pharmaceutical companies to screen targets for anti-platelet development, fundamental test for guarding patients at high risk of bleeding prior to surgery, rise in platelets disorders such as thrombocythemia, and growing acceptance for platelet treatment among cancer patients. The market for platelet aggregation devices is expanding as a result of ongoing platelet aggregometer advancements, as well as the rising prevalence of chronic disorders including arthritis and asthma. Furthermore, the global market for platelet aggregation devices is expanding due to the rise in the number of elderly individuals worldwide.

The development of the market is being fueled by technological developments in platelet aggregation. The market for platelet aggregation devices has grown significantly due to the rise in demand for platelet screening programs to detect illnesses like HIV and dengue. The market for platelet aggregation devices is expanding as a result of an increase in the number of university and industrial researchers collaborating on clinical studies.

The Platelet Aggregation Devices market is experiencing slow growth due to restraints such as a decline in end-user potential and high device purchasing costs. Requirement Platelet aggregation method utilization may decline when using huge volumes of blood, which may have an impact on the Platelet Aggregation Devices market.

Platelet Aggregation Devices Market Share

Due to a large number of device manufacturers, an expanding elderly population, technological advancements in platelet aggregation meters, and growing medical professional awareness of the advantages of platelet aggregation testing in disease diagnosis, the North American region currently holds the largest market share.

Key Segmentations

By Company
• Siemens
• Helena Laboratories
• Haemonetics
• Accriva Diagnostics
• F. Hoffman-la Roche
• Sysmex
• Aggredyne
• Tem
• Sentinel Ch.

Segment by Type
• Systems
• Reagents
• Consumables
• Accessories

Segment by Application
• Hospitals
• Research And Academic Institutes
• Diagnostic Laboratories
• Blood Banks

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-25L7374/global-platelet-aggregation-devices

Similar Reports:

1. https://reports.valuates.com/market-reports/QYRE-Auto-36L5780/global-air-cargo-software

2. https://reports.valuates.com/market-reports/QYRE-Auto-3I9444/global-electric-condensate-pump

3. https://reports.valuates.com/market-reports/QYRE-Auto-24Y7278/global-mes-and-ecqm

U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.